JP2021521230A5 - - Google Patents
Info
- Publication number
- JP2021521230A5 JP2021521230A5 JP2020556885A JP2020556885A JP2021521230A5 JP 2021521230 A5 JP2021521230 A5 JP 2021521230A5 JP 2020556885 A JP2020556885 A JP 2020556885A JP 2020556885 A JP2020556885 A JP 2020556885A JP 2021521230 A5 JP2021521230 A5 JP 2021521230A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- insulin
- chain
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862658372P | 2018-04-16 | 2018-04-16 | |
| US62/658,372 | 2018-04-16 | ||
| PCT/US2019/027484 WO2019204206A1 (en) | 2018-04-16 | 2019-04-15 | Glucose-responsive insulin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021521230A JP2021521230A (ja) | 2021-08-26 |
| JP2021521230A5 true JP2021521230A5 (enExample) | 2022-04-25 |
Family
ID=68239869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020556885A Pending JP2021521230A (ja) | 2018-04-16 | 2019-04-15 | グルコース応答性インスリン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210214412A1 (enExample) |
| EP (1) | EP3781147A4 (enExample) |
| JP (1) | JP2021521230A (enExample) |
| KR (1) | KR20210005630A (enExample) |
| CN (1) | CN112423741A (enExample) |
| AU (1) | AU2019255611A1 (enExample) |
| CA (1) | CA3097359A1 (enExample) |
| WO (1) | WO2019204206A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11052133B2 (en) | 2015-05-06 | 2021-07-06 | Protomer Technologies, Inc. | Glucose responsive insulins |
| EP3939605A1 (en) | 2016-12-09 | 2022-01-19 | Akston Biosciences Corporation | Insulin-fc fusions and methods of use |
| MA50552A (fr) | 2017-11-09 | 2020-09-16 | Novo Nordisk As | Dérivés de liaison à l'albumine sensibles au glucose |
| HUE062719T2 (hu) | 2018-06-29 | 2023-11-28 | Akston Biosciences Corp | Ultra-hosszú hatású inzulin-FC fúziós fehérjék és az alkalmazási eljárások |
| US11267862B2 (en) | 2018-06-29 | 2022-03-08 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| TWI717245B (zh) * | 2019-03-29 | 2021-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 葡萄糖敏感型胰島素衍生物 |
| WO2021022116A1 (en) * | 2019-07-31 | 2021-02-04 | Thermalin Inc. | Insulin analogues with glucose regulated conformational switch |
| KR102865175B1 (ko) | 2019-12-19 | 2025-09-30 | 악스톤 바이오사이언시스 코퍼레이션 | 초-장기 작용 인슐린-fc 융합 단백질 및 사용 방법 |
| US11186623B2 (en) | 2019-12-24 | 2021-11-30 | Akston Bioscience Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| KR20220161422A (ko) * | 2020-03-31 | 2022-12-06 | 프로토머 테크놀로지스 인크. | 비시날 디올에 대한 선택적인 반응을 위한 접합체 |
| LT3972987T (lt) | 2020-04-10 | 2023-09-25 | Akston Biosciences Corporation | Antigenui specifinė imunoterapija, skirta sulietiems covid-19 baltymams ir naudojimo būdai |
| US11192930B2 (en) | 2020-04-10 | 2021-12-07 | Askton Bioscences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| US11198719B2 (en) | 2020-04-29 | 2021-12-14 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| KR20230110505A (ko) * | 2020-11-19 | 2023-07-24 | 프로토머 테크놀로지스 인크. | 방향족 붕소-함유 화합물 및 인슐린 유사체 |
| US11667689B2 (en) | 2021-07-23 | 2023-06-06 | Akston Biosciences Corporation | Insulin-Fc fusion proteins and methods of use to treat cancer |
| WO2023156849A2 (en) * | 2022-02-17 | 2023-08-24 | Revolo Biotherapeutics Limited | Method of producing peptide derived from chaperonin 60.1 |
| PE20251287A1 (es) | 2022-05-18 | 2025-05-14 | Protomer Tech Inc | Compuestos aromaticos que contienen boro y analogos de insulina relacionados |
| WO2025117822A1 (en) * | 2023-11-28 | 2025-06-05 | University Of Notre Dame Du Lac | Glucose-triggered gelation of supramolecular peptide nanocoils with glucose-binding motifs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6070100A (ja) * | 1983-09-26 | 1985-04-20 | Wako Pure Chem Ind Ltd | 新規ヒト型インシュリン誘導体，その製法，及びヒト型インシュリンの製造法 |
| DE3837825A1 (de) * | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| US7317000B2 (en) * | 2001-12-02 | 2008-01-08 | Novo Nordisk A/S | Glucose-dependent insulins |
| EP1453860A2 (en) * | 2001-12-02 | 2004-09-08 | Novo Nordisk A/S | Novel glucose-dependant insulins |
| US7928186B2 (en) * | 2006-08-02 | 2011-04-19 | Phoenix Pharmaceuticals, Inc. | Cell permeable bioactive peptide conjugates |
| BR112012020481A2 (pt) * | 2010-02-22 | 2017-01-10 | Univ Case Western Reserve | método para tratar um paciente, o método compreendendo administrar uma formulação farmacêutica contendo uma quantidade fisiologicamente efetiva de um análogo de insulina ou um sal fisiologicamente. |
| UA113626C2 (xx) * | 2011-06-02 | 2017-02-27 | Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії | |
| US20160031962A1 (en) * | 2012-04-20 | 2016-02-04 | Kleomenis K. Barlos | Solid phase peptide synthesis of insulin using side chain achored lysine |
| US9867869B2 (en) * | 2012-12-12 | 2018-01-16 | Massachusetts Institute Of Technology | Insulin derivatives for diabetes treatment |
| US11052133B2 (en) * | 2015-05-06 | 2021-07-06 | Protomer Technologies, Inc. | Glucose responsive insulins |
-
2019
- 2019-04-15 CN CN201980031925.3A patent/CN112423741A/zh active Pending
- 2019-04-15 AU AU2019255611A patent/AU2019255611A1/en not_active Abandoned
- 2019-04-15 US US17/040,973 patent/US20210214412A1/en not_active Abandoned
- 2019-04-15 JP JP2020556885A patent/JP2021521230A/ja active Pending
- 2019-04-15 WO PCT/US2019/027484 patent/WO2019204206A1/en not_active Ceased
- 2019-04-15 CA CA3097359A patent/CA3097359A1/en active Pending
- 2019-04-15 KR KR1020207032777A patent/KR20210005630A/ko not_active Ceased
- 2019-04-15 EP EP19789533.7A patent/EP3781147A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1360202B1 (en) | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders | |
| JP7596268B2 (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに活性を有する三重活性体と、インスリンとを含む薬学組成物 | |
| JP2018515088A5 (enExample) | ||
| AU2020279968B2 (en) | Variant single-chain insulin analogues | |
| JP2014534265A5 (enExample) | ||
| CA2862516A1 (en) | Compositions and methods of use for treating metabolic disorders | |
| JP7536030B2 (ja) | 増殖分化因子１５併用療法 | |
| US10822386B2 (en) | Insulin analogues with enhanced stability and reduced mitogenicity | |
| CN105324397A (zh) | 胰岛素-肠促胰岛素缀合物 | |
| JP2017536337A5 (enExample) | ||
| JP2013501818A (ja) | 修飾された血管作動性腸管ペプチド | |
| EP2373681A1 (en) | Pharmaceutical compositions | |
| CN107108716A (zh) | 双相性单链胰岛素类似物 | |
| JP2021533204A5 (enExample) | ||
| EP2804621A1 (en) | Glutamic acid-stabilized insulin analogues | |
| JP2022551233A (ja) | 異なる構造のｇｌｐ－１アナログペプチド修飾二量体およびその調製方法のｉｉ型糖尿病の治療における用途 | |
| CN103501801A (zh) | 甲状旁腺激素类似物、其组合物和用途 | |
| JP2017500316A5 (enExample) | ||
| CN106279430B (zh) | Exendin‑4类似物融合蛋白及其制备方法和用途 | |
| JP2017524675A5 (enExample) | ||
| WO2022227707A1 (zh) | 一种双靶点融合蛋白的制备方法和应用 | |
| JP2010043001A (ja) | Ｇｌｐ−１誘導体とその用途 | |
| JP2014519514A5 (enExample) | ||
| WO2015180634A1 (zh) | 用于治疗2型糖尿病的长效肠激素多肽类似物及应用 | |
| Linderoth et al. | GLP‐1 Receptor Agonists for the Treatment of Type 2 Diabetes and Obesity |